1-7 of 7
Louise M. Treanor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preservation of T-Cell Stemness with a Novel Expansionless CAR-T Manufacturing Process, Which Reduces Manufacturing Time to Less Than Two Days, Drives Enhanced CAR-T Cell Efficacy

Boris Engels, Xu Zhu, Jennifer Yang, Andrew Price, Akash Sohoni, Andrew M Stein, Lana Parent, Michael Greene, Matthew Niederst, Jeanne Whalen, Elena J Orlando, Louise M Treanor, Jennifer L Brogdon
Journal: Blood
Blood (2021) 138 (Supplement 1): 2848.
https://doi.org/10.1182/blood-2021-146246
Published: 2021
Journal Articles

Phase I Study of PHE885, a Fully Human BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <2 Days Using the T-Charge TM Platform

Adam S. Sperling, Sarah Nikiforow, Omar Nadeem, Clifton C Mo, Jacob P. Laubach, Kenneth C. Anderson, Alejandro Alonso, Shuntaro Ikegawa, Rao Prabhala, Diego Hernandez Rodriguez, Heather Daley, Kit L. Shaw, Yohei Arihara, Soudeh Ansari, David S Quinn, David Pearson, Anniesha Hack, Louise M Treanor, Dexiu Bu, Jennifer Mataraza, Lawrence Rispoli, Marc Credi, Jerome Ritz, Serena De Vita, Nikhil C. Munshi
Journal: Blood
Blood (2021) 138 (Supplement 1): 3864.
https://doi.org/10.1182/blood-2021-146646
Published: 2021
Journal Articles

Identification and Development of PHE885: A Novel and Highly Potent Fully Human Anti-BCMA CAR-T Manufactured with a Novel T-Charge TM Platform for the Treatment of Multiple Myeloma

Dexiu Bu, Paul Bennett, Nathaniel Barton, Laura Bradshaw, Maria Pinon-Ortiz, Xiangen Li, Poonam Vaidya, Xu Zhu, Keith Mansfield, Brian Granda, Carla P Guimaraes, Louise M Treanor, Jennifer L Brogdon
Journal: Blood
Blood (2021) 138 (Supplement 1): 2770.
https://doi.org/10.1182/blood-2021-148390
Published: 2021
Journal Articles

N-Myc Is Overexpressed In Both Murine and Human Early T-Cell Precursor Leukemia and Is Sufficient To Initiate this Leukemia In Multipotent Primitive Arf -/- thymocytes

Louise M. Treanor, PhD, Sheng Zhou, PhD, Yu Fukuda, PhD, Nandakumar Satish, David Finkelstein, PhD, John D. Schuetz, PhD, Charles G. Mullighan, MBBS, MSc, MD, FRACP, FRCPA, Brian P. Sorrentino, MD
Journal: Blood
Blood (2013) 122 (21): 348.
https://doi.org/10.1182/blood.V122.21.348.348
Published: 2013
Journal Articles

Lmo2 Overexpression and Arf Loss Induce Myeloid Differentiation in Primitive Thymocytes

Louise M. Treanor, PhD, Sheng Zhou, PhD, Taihe Lu, PhD, Charles G Mullighan, MBBS, MD, FRACP, FRCPA, MSc, Brian P. Sorrentino, MD
Journal: Blood
Blood (2011) 118 (21): 47.
https://doi.org/10.1182/blood.V118.21.47.47
Published: 2011
Journal Articles

Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies

Louise M. Treanor, Emmanuel J. Volanakis, Sheng Zhou, Taihe Lu, Charles J. Sherr, Brian P. Sorrentino
Journal: Blood
Blood (2011) 117 (20): 5453–5462.
https://doi.org/10.1182/blood-2010-09-309831
Published: 2011
Includes: Supplemental data
Journal Articles

Loss of p19 Arf Increases the Self-Renewal Capacity of Immature Thymocytes That Over-Express LMO2

Louise M. Treanor, PhD, Sheng Zhou, PhD, Taihe Lu, Brian P. Sorrentino, MD
Journal: Blood
Blood (2010) 116 (21): 4198.
https://doi.org/10.1182/blood.V116.21.4198.4198
Published: 2010